Clinical trial Recruiting at 1 site Observational Ages 6 to 70

Headache registration and follow-up program at Tongji Hospital

Official title: Headache Registration and Followup Initiated by Tongji Hospital, HUST

Run by Tongji Hospital · NCT07269561 · Data updated 2026-11-12

This program will collect clinical records, imaging, questionnaires, and blood samples from people aged 6–70 with diagnosed headaches to build a large database to help develop better diagnosis and treatments.

Quick facts

Study typeObservational
Ages6 Years to 70 Years
SexAll
Enrollment50000 (estimated)
SponsorTongji Hospital
Academic / other
Drugs / interventionsimmunotherapy
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedDecember 8, 2025
Trial IDNCT07269561 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 6–70 who meet ICHD-3 headache diagnostic criteria, can give informed consent (or have guardian consent), and can comply with follow-up and questionnaires.

Probably not a fit

Patients with highly complex headache etiologies (three or more distinct causes), severe systemic disease with life expectancy under ten years, or major cognitive/psychiatric impairments that prevent follow-up are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, prospective observational cohort led by Tongji Hospital that aims to enroll up to 50,000 participants with clinical data and 1,500 participants who provide biological specimens. Initial data collection includes epidemiological information, clinical assessments, imaging, standardized questionnaires, and a 5 ml venous blood sample, with planned multi-omics and biobanking. Participants will be followed for up to 10 years with face-to-face visits in the first three months and annual telephone follow-ups thereafter to record medication use, clinical outcomes, and adverse events. The project will build integrated clinical and multi-omics databases and apply machine-learning and bioinformatics to identify diagnostic markers, drug targets, and precision treatment strategies.

Why it matters

Potential benefit: If successful, this program could lead to more accurate diagnoses, personalized treatment approaches, and identification of new biological targets for people with headaches.

How similar studies have gone: While large population headache cohorts and some biomarker studies exist, combining long-term multi-omics biobanking with machine-learning for precision headache diagnosis and treatment is relatively novel and not yet widely proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meeting the diagnostic criteria for headache classification according to the International Classification of Headache Disorders 3rd edition (ICHD-3, 2018) Age between 6-70 years Voluntary participation with consent Good compliance with follow-up and questionnaire surveys

Exclusion Criteria:

* Complex headache etiology, e.g., presence of ≥3 distinct factors causing headache Presence of severe systemic diseases or life expectancy less than 10 years Significant cognitive or psychiatric issues that prevent completion of questionnaire follow-ups and clinical assessments

Where it's running

  • Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.